More Press Releases

View Older Stories View Newer Stories

Dec 8, 2024 10:47AM Siemon Releases 2024 ESG Report: A Commitment to Sustainability
Dec 8, 2024 10:45AM Notice of Convening Hearing
Dec 8, 2024 09:58AM Max Stock Limited: Immediate report of changes to interested party holdings
Dec 8, 2024 09:55AM National Press Club: Family Of Austin Tice Available for Interviews at St. John's Church
Dec 8, 2024 09:35AM Remarkable Determination: A Contestant Submitted 200 Entries, Yet None Reached The Longlist
Dec 8, 2024 09:00AM Renovate.com Bridges Home Improvement Gap by Prequalifying Financing and Connecting Homeowners With Contractors
Dec 8, 2024 08:40AM XMX LONDON LIMITED Celebrates 20 Years of Excellence in High End Residential Construction and Commercial Building Development
Dec 8, 2024 08:26AM Nanning: A Colorful City of Cultural Diversity
Dec 8, 2024 08:00AM Monster Energy's David Wise Claims Third Place in Men's Freeski Halfipe at the FIS World Cup at China's Secret Garden
Dec 8, 2024 08:00AM The Best Christmas Gift Ideas for 2024: Transformative Skincare with a Special Holiday Twist
Dec 8, 2024 07:27AM Riyadh Action Agenda Gathers Steam as Land Governance Takes Center Stage at UNCCD COP16
Dec 8, 2024 07:13AM FinCEN and DOJ Appeal Corporate Transparency Act Nationwide Injunction Two Days After Texas Ruling on BOIR
Dec 8, 2024 06:00AM Vision Marine and Armada Partner to Produce an Innovative Electric Pontoon for North America’s Regulated Lakes
Dec 8, 2024 05:25AM Riyadh International Philosophy Conference 2024 Concludes with a Focus on Quality of Life
Dec 8, 2024 02:52AM RBB Law Group Partners with Amazon to Transform Car Buying and Ensure Fair Rebates Nationwide
Dec 8, 2024 02:32AM EliteSignals Unveils Revolutionary Forex Trading Bot: EliteX
Dec 8, 2024 01:56AM DKbitex to Launch DKBC: A Revolutionary New Cryptocurrency
Dec 8, 2024 01:36AM Hosted.com Launches AI-Powered Domain Name Generator, Simplifying The Domain Registration Process
Dec 8, 2024 01:36AM Staking AI Redefines Crypto Investments: Discover the Highest APY Platform of 2024
Dec 8, 2024 01:36AM ZeusX Celebrates Milestones in Connecting Gamers Through a Secure Marketplace
Dec 8, 2024 01:00AM PRIME MINISTER OF MONGOLIA MAKES HISTORIC VISIT TO MIDDLE EAST
Dec 7, 2024 11:01PM Icona Capital Acquires Island In Maldives for an Ultra-Luxury Project
Dec 7, 2024 11:02PM Global Times: Clay Figure Zhang's works naturally reflect spiritual state of the times
Dec 7, 2024 03:34AM DKbitex to Launch DKDC: A Revolutionary New Cryptocurrency
Dec 7, 2024 09:14PM University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
Dec 7, 2024 07:12PM Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Dec 7, 2024 07:00PM Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab
Dec 7, 2024 07:00PM Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
Dec 7, 2024 07:00PM Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Dec 7, 2024 07:00PM Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Dec 7, 2024 07:00PM Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Dec 7, 2024 06:30PM Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
Dec 7, 2024 06:15PM Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
Dec 7, 2024 06:09PM Twenty-three Years Running for the Kids of St. Jude: St. Jude Memphis Marathon Weekend Reaches Fundraising Record
Dec 7, 2024 05:39PM Caribbean Airlines Brings the Region Closer with New Service to Guadeloupe
Dec 7, 2024 05:00PM New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients
Dec 7, 2024 04:53PM MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US Environmental Protection Agency
Dec 7, 2024 03:59PM Pennsylvania Skill, powered by Pace-O-Matic, Responds to Commonwealth Court Ruling in Favor of Skill Games
Dec 7, 2024 03:46PM Building Homes for Heroes Gifts 400th Home, Marking Historic Achievement in Veteran and First Responder Support
Dec 7, 2024 03:30PM HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)
Dec 7, 2024 03:21PM United Flow Technologies Acquires The TDH Company to Enhance Water and Wastewater Treatment Solutions
Dec 7, 2024 03:10PM Admirals Group AS Announces a Sale of its Australian Subsidiary
Dec 7, 2024 01:00PM OpsHub Amplifies its Presence on the Visual Studio (VSTS) Marketplace
Dec 7, 2024 12:33PM Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relaps
Dec 7, 2024 12:30PM Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia
Dec 7, 2024 12:30PM Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
Dec 7, 2024 12:30PM Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Dec 7, 2024 12:25PM Guan Hu's BLACK DOG Nominated for Best International Film For Film Independent Spirit Award
Dec 7, 2024 11:09AM Edwards Lifesciences Corporation Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Dec 7, 2024 12:00PM Fred Says Foundation Announces Its 2024 Gifts for World AIDS Day
View Newer Stories View Older Stories